EX-FILING FEES 4 ex_550687.htm EXHIBIT FILING FEES ex_550687.htm

 

EXHIBIT 107

 

Calculation of Filing Fee Tables

 

Form S-3

 

(Form Type)

 

AcelRx Pharmaceuticals, Inc.

 

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

 

Security Type

Security Class
Title

Fee Calculation
or Carry
Forward Rule

Amount
Registered

Proposed
Maximum
Offering Price
Per Unit

Maximum
Aggregate
Offering Price

Fee Rate

Amount of
Registration
Fee

Fees to Be Paid

Equity

Common Stock, par value $0.001 per share

457(c)

22,426,488(1)

$0.975(2)

$21,865,826(2)

$0.00011020

$2,410(2)
 

Total Offering Amounts

    

$21,865,826

—

$2,410
 

Total Fee Offsets

        

—
 

Net Fee Due

        

$2,410

 

(1)

Consists of 22,426,488 shares of the Registrant’s common stock registered for resale by the selling stockholders named in this registration statement.

 

(2)

Estimated solely for the purposes of calculating the registration fee. Pursuant to Rule 457(c) under the Securities Act, the registration fee has been calculated based upon the average of the high and low prices, as reported by The Nasdaq Global Market, for shares of the Registrant’s common stock on July 27, 2023.